Financials
- Market Capitalization 362.19 M
- Employee 45
- Founded 2019
- CEO N/A
- Website www.x4pharma.com
- Headquarter Delaware, United States
- FIGI BBG001J1CYH8
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-2
市销率
11.96
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 3163 | FENC Fennec Pharmaceuticals Inc. - Common Stock | 10.62 USD | -4.84% | +3.71% | +14.07% | +20.27% | 368.91 M USD | ||
| 3165 | LXEO Lexeo Therapeutics, Inc. - Common Stock | 4.69 USD | +1.52% | -7.31% | -0.64% | +12.74% | 368.27 M USD | ||
| 3188 | PRLD Prelude Therapeutics Incorporated - Common Stock | 4.50 USD | +2.51% | -10.89% | +2.97% | +455.56% | 358.40 M USD | ||
| 3199 | PALI Palisade Bio, Inc. - Common Stock | 2.04 USD | +5.70% | +3.03% | +21.43% | +20.00% | 354.10 M USD |